Latest period
$1.45B
YoY change
+443.9%
5Y CAGR
—
Peak year (2025)
$1.35B
Latest annual
$1.35B
Free Cash Flow history chart for Incyte (INCY) from 1993 to 2025
Latest: $1.35B
Free Cash Flow growth chart for Incyte (INCY) from 1993 to 2025
Latest: +443.9%
Free Cash Flow history table for Incyte (INCY) from 1993 to 2025
| 2025 | $1.35B | +443.9% | +$1.11B | ||
| 2024 | $249.07M | -44.5% | −$199.93M | ||
| 2023 | $449.00M | -49.7% | −$443.11M | ||
| 2022 | $892.11M | +56.9% | +$323.63M | ||
| 2021 | $568.48M | -282.2% | +$880.46M | ||
| 2020 | −$311.98M | -149.3% | −$944.57M | ||
| 2019 | $632.59M | +140.8% | +$369.85M | ||
| 2018 | $262.74M | -228.8% | +$466.75M | ||
| 2017 | −$204.01M | -210.6% | −$388.49M | ||
| 2016 | $184.48M | +204.8% | +$123.95M | ||
| 2015 | $60.53M | -3836.6% | +$62.15M | ||
| 2014 | −$1.62M | -133.0% | −$6.53M | ||
| 2013 | $4.91M | -105.0% | +$102.58M | ||
| 2012 | −$97.67M | -41.0% | +$67.84M | ||
| 2011 | −$165.51M | -276.4% | −$259.34M | ||
| 2010 | $93.83M | +683.8% | +$81.86M | ||
| 2009 | $11.97M | -108.5% | +$153.53M | ||
| 2008 | −$141.56M | +50.8% | −$47.71M | ||
| 2007 | −$93.85M | +80.7% | −$41.91M | ||
| 2006 | −$51.94M | -49.8% | +$51.57M | ||
| 2005 | −$103.50M | -10.8% | +$12.55M | ||
| 2004 | −$116.06M | -9.4% | +$12.01M | ||
| 2003 | −$128.07M | +82.6% | −$57.91M | ||
| 2002 | −$70.16M | +17.1% | −$10.23M | ||
| 2001 | −$59.92M | -42.2% | +$43.80M | ||
| 2000 | −$103.72M | +84.6% | −$47.52M | ||
| 1999 | −$56.20M | -3846.7% | −$57.70M | ||
| 1998 | $1.50M | -120.3% | +$8.90M | ||
| 1997 | −$7.40M | +76.2% | −$3.20M | ||
| 1996 | −$4.20M | -75.1% | +$12.70M | ||
| 1995 | −$16.90M | +89.9% | −$8.00M | ||
| 1994 | −$8.90M | +85.4% | −$4.10M | ||
| 1993 | −$4.80M | — | — |
- 2025$1.35B+443.9%
- 2024$249.07M-44.5%
- 2023$449.00M-49.7%
- 2022$892.11M+56.9%
- 2021$568.48M-282.2%
- 2020−$311.98M-149.3%
- 2019$632.59M+140.8%
- 2018$262.74M-228.8%
- 2017−$204.01M-210.6%
- 2016$184.48M+204.8%
- 2015$60.53M-3836.6%
- 2014−$1.62M-133.0%
- 2013$4.91M-105.0%
- 2012−$97.67M-41.0%
- 2011−$165.51M-276.4%
- 2010$93.83M+683.8%
- 2009$11.97M-108.5%
- 2008−$141.56M+50.8%
- 2007−$93.85M+80.7%
- 2006−$51.94M-49.8%
- 2005−$103.50M-10.8%
- 2004−$116.06M-9.4%
- 2003−$128.07M+82.6%
- 2002−$70.16M+17.1%
- 2001−$59.92M-42.2%
- 2000−$103.72M+84.6%
- 1999−$56.20M-3846.7%
- 1998$1.50M-120.3%
- 1997−$7.40M+76.2%
- 1996−$4.20M-75.1%
- 1995−$16.90M+89.9%
- 1994−$8.90M+85.4%
- 1993−$4.80M—
Free Cash Flow values are taken from Incyte's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Incyte (INCY)
Free Cash Flow for Incyte (INCY): headline value $1.45B · YoY +443.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Incyte (INCY) free cash flow is $1.35B – surged 443.9% year-over-year.
Looking at the 2015–2025 (10 years) stretch, Incyte free cash flow compounded at +36.5% per year, with mixed annual results across the window.
The record annual free cash flow stands at $1.35B, reached in 2025; the historical low of −$311.98M was recorded in 2020.
Incyte Free Cash Flow by Year
Incyte Free Cash Flow 2025: $1.35B
Incyte free cash flow in 2025 was $1.35B, surged 443.9% from 2024. This figure represents the highest annual value in the available history.
Incyte Free Cash Flow 2024: $249.07M
2024's free cash flow for Incyte came in at $249.07M, plunged 44.5% below 2023.
Incyte Free Cash Flow 2023: $449.00M
Incyte posted free cash flow of $449.00M in 2023, plunged 49.7% below 2022.
Incyte Free Cash Flow 2022: $892.11M
In 2022, Incyte reported free cash flow of $892.11M, surged 56.9% from 2021.
Incyte Free Cash Flow 2021: $568.48M
Incyte free cash flow in 2021 was $568.48M.
See more financial history for Incyte (INCY).
Sector peers by Free Cash Flow
Healthcare peers of Incyte (INCY), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Incyte (INCY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation